Roslyn Davis - Concepedia

Author

Roslyn Davis

CSL (Australia)

Also Known As

R. Aleks Davis, R. Davis, Roslyn Davis

Publications

695

Citations

H-Index

Concepts

All Affiliations

CSL (Australia)CSL (United States)Eli Lilly (United States)The Royal Melbourne Hospital

About

Roslyn Davis is an author at CSL (Australia) specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	289
2	Immunology	3	3	103
3	Pharmacology	2	2	113
4	Allergy	1	1	13
5	Autoimmune Disease	1	1	13

Roslyn Davis

Publications

680

Citations

H-Index

Page 1

	Year	Citations
Atorvastatin increases human serum levels of proprotein convertase subtilisin/kexin type 9 Holly E. Careskey, Roslyn Davis, William E. Alborn, Journal of Lipid Research	2007	310
Intranasal vaccination with ISCOMATRIX® adjuvanted influenza vaccine A.R. Coulter, Rodney Harris, Roslyn Davis, Vaccine VaccinationVaccinologyVaccine DevelopmentInfluenza VaccineFlu Vaccination	2003	102
A multiple ascending dose study of CSL112, an infused formulation of ApoA‐I Rachael Easton, Andreas Gille, Denise D’Andrea, The Journal of Clinical Pharmacology ThrombosisPharmaceutical ScienceCsl112 InfusionsHealthy SubjectsCardiovascular Disease	2013	84
Intranasal immunisation with influenza-ISCOM induces strong mucosal as well as systemic antibody and cytotoxic T-lymphocyte responses Sigrid Sjölander, Debbie Drane, Roslyn Davis, Vaccine Mucosal VaccinationSystemic AntibodyCytotoxic T-lymphocyte ResponsesHumoral ResponseImmunology	2001	61
First-in Man, Phase 1 Study of CSL362 (Anti-IL3Rα / Anti-CD123 Monoclonal Antibody) in Patients with CD123+ Acute Myeloid Leukemia (AML) in CR at High Risk for Early Relapse B. Douglas Smith, Gail J. Roboz, Roland B. Walter, Blood	2014	60
Plasma-Derived Hemopexin as a Candidate Therapeutic Agent for Acute Vaso-Occlusion in Sickle Cell Disease: Preclinical Evidence Thomas Gentinetta, John D. Belcher, Valérie Brügger‐Verdon, Journal of Clinical Medicine InflammationThrombosisAcute Vaso-occlusionSickle Cell DiseasePlasma-derived Hemopexin	2022	29
A Phase 1 and Correlative Biological Study of CSL360 (anti-CD123 mAb) in AML Andrew W. Roberts, Simon He, Kenneth F. Bradstock, Blood	2008	21
A novel method for quantitative measurement of a biomarker in the presence of a therapeutic monoclonal antibody directed against the biomarker Roslyn Davis, Anthony Butterfield, Robert J. Konrad, Journal of Pharmaceutical and Biomedical Analysis Biomarker (Medicine)Translational MedicineNovel MethodImmunocytochemical TechniqueAllergy	2008	13

Page 1